Johnson & Johnson Vision Receives FDA Clearance and CE Mark for Next-Generation Phacoemulsification Machine, VERITAS™ Vision System
Go back to Johnson & Johnson Vision Receives FDA Clearance and CE Mark for Next-Generation Phacoemulsification Machine, VERITAS™ Vision System| Johnson & Johnson (NYSE: JNJ) | Delayed: 149.56 +0.44 (0.30%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $149.12 | 52 Week High | $126.07 | |||
| Open | $149.86 | 52 Week Low | $94.28 | |||
| Day High | $150.49 | P/E | 31.09 | |||
| Day Low | $148.20 | EPS | $4.81 | |||
| Volume | 10,110,432 | |||||
